Ocular Therapeutix, Inc. (OCUL)
NASDAQ·Healthcare·Biotechnology
$9.32
-2.21%
Mkt Cap $2.03B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $16.13M | $13.25M | -17.85% | -$0.33 | -$0.29 | +12.12% | — | — |
| Q4 2025 Nov 4, 2025 | $16.14M | $14.54M | -9.90% | -$0.39 | -$0.37 | +5.13% | — | — |
| Q3 2025 Aug 5, 2025 | $14.57M | $13.46M | -7.60% | -$0.35 | -$0.39 | -11.43% | — | — |
| Q2 2025 May 5, 2025 | $13.10M | $10.63M | -18.80% | -$0.29 | -$0.37 | -27.59% | — | — |
| Q1 2025 Mar 3, 2025 | $17.11M | $17.08M | -0.17% | -$0.24 | -$0.29 | -20.83% | — | — |
| Q4 2024 Nov 14, 2024 | $16.89M | $15.43M | -8.68% | -$0.23 | -$0.26 | -13.04% | — | — |
| Q3 2024 Aug 7, 2024 | $15.82M | $16.44M | +3.93% | -$0.22 | -$0.24 | -9.09% | — | — |
| Q2 2024 May 7, 2024 | $15.41M | $14.71M | -4.51% | -$0.18 | -$0.24 | -33.33% | — | — |
| Q1 2024 Mar 11, 2024 | $15.71M | $14.80M | -5.78% | -$0.28 | -$0.28 | +0.00% | — | — |
| Q4 2023 Nov 7, 2023 | $15.87M | $14.95M | -5.80% | -$0.27 | -$0.51 | -88.89% | — | — |
| Q3 2023 Aug 7, 2023 | $14.65M | $15.19M | +3.66% | -$0.29 | -$0.27 | +6.90% | — | — |
| Q2 2023 May 8, 2023 | $14.10M | $13.37M | -5.15% | -$0.27 | -$0.31 | -14.81% | — | — |
| Q1 2023 Mar 6, 2023 | $13.53M | $14.08M | +4.01% | -$0.25 | -$0.24 | +4.00% | — | — |
| Q4 2022 Nov 7, 2022 | $14.27M | $11.96M | -16.16% | -$0.23 | -$0.30 | -30.43% | — | — |
| Q3 2022 Aug 8, 2022 | $14.25M | $12.27M | -13.91% | -$0.23 | -$0.28 | -21.74% | — | — |
| Q2 2022 May 9, 2022 | $13.96M | $13.19M | -5.52% | -$0.25 | -$0.22 | +12.00% | — | — |
| Q1 2022 Feb 28, 2022 | $13.94M | $12.31M | -11.71% | -$0.23 | -$0.23 | +0.00% | — | — |
| Q4 2021 Nov 8, 2021 | $13.88M | $12.15M | -12.44% | -$0.26 | -$0.23 | +11.54% | — | — |
| Q3 2021 Aug 9, 2021 | $11.72M | $11.72M | +0.00% | -$0.20 | -$0.25 | -25.00% | — | — |
| Q2 2021 May 5, 2021 | $9.76M | $7.34M | -24.77% | -$0.20 | -$0.24 | -20.00% | — | — |